-
1
-
-
0032476644
-
Nonsteroidal anti-inflammatory drug-related gastrointestinal toxicity: Definitions and epidemiology
-
McCarthy D. Nonsteroidal anti-inflammatory drug-related gastrointestinal toxicity: definitions and epidemiology. Am J Med 1998; 105: 3S-9S.
-
(1998)
Am J Med
, vol.105
-
-
McCarthy, D.1
-
2
-
-
0033965104
-
Pharmacoepidemiology of non-steroidal anti-inflammatory drug use in Nottingham general practices
-
Cullen DJ, Seager JM, Holmes S, et al. Pharmacoepidemiology of non-steroidal anti-inflammatory drug use in Nottingham general practices. Aliment Pharmacol Ther 2000; 14: 177-85.
-
(2000)
Aliment Pharmacol Ther
, vol.14
, pp. 177-185
-
-
Cullen, D.J.1
Seager, J.M.2
Holmes, S.3
-
3
-
-
0033978372
-
Gastroesophageal reflux disease: Prevalence, clinical, endoscopic and histopathological findings in 1128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms
-
Voutilainen M, Sipponen P, Mecklin JP, Juhola M, Farkkila M. Gastroesophageal reflux disease: prevalence, clinical, endoscopic and histopathological findings in 1128 consecutive patients referred for endoscopy due to dyspeptic and reflux symptoms. Digestion 2000; 61: 6-13.
-
(2000)
Digestion
, vol.61
, pp. 6-13
-
-
Voutilainen, M.1
Sipponen, P.2
Mecklin, J.P.3
Juhola, M.4
Farkkila, M.5
-
4
-
-
0033925632
-
The comparative risk and predictors of adverse gastrointestinal events in rheumatoid arthritis and osteoarthritis: A prospective 13 year study of 2131 patients
-
Wolfe F, Hawley DJ. The comparative risk and predictors of adverse gastrointestinal events in rheumatoid arthritis and osteoarthritis: a prospective 13 year study of 2131 patients. J Rheumatol 2000; 27: 1668-73.
-
(2000)
J Rheumatol
, vol.27
, pp. 1668-1673
-
-
Wolfe, F.1
Hawley, D.J.2
-
5
-
-
0034857583
-
Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease in a Medicaid population
-
Kotzan J, Wade W, Yu HH. Assessing NSAID prescription use as a predisposing factor for gastroesophageal reflux disease in a Medicaid population. Pharm Res 2001; 18: 1367-72.
-
(2001)
Pharm Res
, vol.18
, pp. 1367-1372
-
-
Kotzan, J.1
Wade, W.2
Yu, H.H.3
-
6
-
-
0036936615
-
The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors
-
Laine L. The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors. Semin Arthritis Rheum 2002; 32 (3 Suppl. 1): 25-32.
-
(2002)
Semin Arthritis Rheum
, vol.32
, Issue.3 SUPPL. 1
, pp. 25-32
-
-
Laine, L.1
-
7
-
-
0033601079
-
Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs
-
Langman MJ, Jensen DM, Watson DJ, et al. Adverse upper gastrointestinal effects of rofecoxib compared with NSAIDs. JAMA 1999; 282: 1929-33.
-
(1999)
JAMA
, vol.282
, pp. 1929-1933
-
-
Langman, M.J.1
Jensen, D.M.2
Watson, D.J.3
-
8
-
-
0034644396
-
Gastrointestinal toxicity with celecoxib vs. nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: a randomized controlled trial. Celecoxib long-term arthritis safety study
-
Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinal toxicity with celecoxib vs. nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib long-term arthritis safety study. JAMA 2000; 282: 1247-55.
-
(2000)
JAMA
, vol.282
, pp. 1247-1255
-
-
Silverstein, F.E.1
Faich, G.2
Goldstein, J.L.3
-
9
-
-
0142028961
-
Gastrointestinal tolerability and effectiveness of rofecoxib vs. naproxen in the treatment of osteoarthritis: A randomized, controlled trial
-
Lisse JE, Perlman M, Johannson G, et al. Gastrointestinal tolerability and effectiveness of rofecoxib vs. naproxen in the treatment of osteoarthritis: a randomized, controlled trial. Ann Inter Med 2003; 139: 539-46.
-
(2003)
Ann Inter Med
, vol.139
, pp. 539-546
-
-
Lisse, J.E.1
Perlman, M.2
Johannson, G.3
-
10
-
-
20444467682
-
Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: An update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool
-
Veldhuyzen van Zanten SJO, Bradette M, Chiba N, et al. Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool. Can J Gastroenterol 2005; 19: 285-303.
-
(2005)
Can J Gastroenterol
, vol.19
, pp. 285-303
-
-
Veldhuyzen van Zanten, S.J.O.1
Bradette, M.2
Chiba, N.3
-
11
-
-
0032066149
-
NSAID induced gastrointestinal complications: The ARAMIS perspective-1997. Arthritis, Rheumatism, and Aging Medical Information System
-
Singh G, Rosen Ramey D. NSAID induced gastrointestinal complications: the ARAMIS perspective-1997. Arthritis, Rheumatism, and Aging Medical Information System. J Rheumatol Suppl 1998; 25 (Suppl. 51): 8-16.
-
(1998)
J Rheumatol Suppl
, vol.25
, Issue.SUPPL. 51
, pp. 8-16
-
-
Singh, G.1
Rosen Ramey, D.2
-
12
-
-
0029982324
-
Indomethacin damage to rat gastric mucosa is markedly dependent on luminal pH
-
Elliot SL, Ferris RJ, Giraud AS, et al. Indomethacin damage to rat gastric mucosa is markedly dependent on luminal pH. Clin Exp Pharmacol Physiol 1996; 23: 432-4.
-
(1996)
Clin Exp Pharmacol Physiol
, vol.23
, pp. 432-434
-
-
Elliot, S.L.1
Ferris, R.J.2
Giraud, A.S.3
-
13
-
-
0034763257
-
Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs
-
McCarthy DM. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs. Best Pract Clin Gastroenterol 2001; 15: 755-73.
-
(2001)
Best Pract Clin Gastroenterol
, vol.15
, pp. 755-773
-
-
McCarthy, D.M.1
-
14
-
-
0030016432
-
Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal antiinflammatory drug therapy. A Nordic multicentre study
-
Ekstrom P, Carling L, Wetterhus S, et al. Prevention of peptic ulcer and dyspeptic symptoms with omeprazole in patients receiving continuous non-steroidal antiinflammatory drug therapy. A Nordic multicentre study. Scand J Gastroenterol 1996; 31: 753-8.
-
(1996)
Scand J Gastroenterol
, vol.31
, pp. 753-758
-
-
Ekstrom, P.1
Carling, L.2
Wetterhus, S.3
-
15
-
-
0035658894
-
Quality of life in chronic NSAID users: A comparison of the effect of omeprazole and misoprostol
-
Yeomans N, Wilson I, Langstrom G, et al. Quality of life in chronic NSAID users: a comparison of the effect of omeprazole and misoprostol. Scand J Rheumatol 2001; 30: 328-34.
-
(2001)
Scand J Rheumatol
, vol.30
, pp. 328-334
-
-
Yeomans, N.1
Wilson, I.2
Langstrom, G.3
-
16
-
-
19144370104
-
Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitors
-
Hawkey C, Talley NJ, Yeomans ND, et al. Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitors. Am J Gastroenterol 2005; 100: 1028-36.
-
(2005)
Am J Gastroenterol
, vol.100
, pp. 1028-1036
-
-
Hawkey, C.1
Talley, N.J.2
Yeomans, N.D.3
-
17
-
-
33645449670
-
Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors
-
Scheiman JM, Yeomans ND, Talley NJ, et al. Prevention of ulcers by esomeprazole in at-risk patients using non-selective NSAIDs and COX-2 inhibitors. Am J Gastroenterol 2006; 101: 701-10.
-
(2006)
Am J Gastroenterol
, vol.101
, pp. 701-710
-
-
Scheiman, J.M.1
Yeomans, N.D.2
Talley, N.J.3
-
18
-
-
33644819475
-
Healing of gastric ulcers with esomeprazole vs. ranitidine in patients who continued to receive NSAID therapy: A randomized trial
-
Goldstein JL, Johansen JF, Suchower LJ, Brown KA. Healing of gastric ulcers with esomeprazole vs. ranitidine in patients who continued to receive NSAID therapy: a randomized trial. Am J Gastroenterol 2005; 100: 2650-7.
-
(2005)
Am J Gastroenterol
, vol.100
, pp. 2650-2657
-
-
Goldstein, J.L.1
Johansen, J.F.2
Suchower, L.J.3
Brown, K.A.4
-
19
-
-
0032216688
-
Validation of seven graded diary cards for severity of dyspeptic symptoms in patients with non-ulcer dyspepsia
-
Junghard O, Lauritsen K, Talley NJ, et al. Validation of seven graded diary cards for severity of dyspeptic symptoms in patients with non-ulcer dyspepsia. Eur J Surg Suppl 1998; 583: 106-11.
-
(1998)
Eur J Surg Suppl
, vol.583
, pp. 106-111
-
-
Junghard, O.1
Lauritsen, K.2
Talley, N.J.3
-
20
-
-
33745653498
-
Validation of a 4-graded scale for severity of heartburn in symptomatic GERD patients [abstract]
-
Junghard O, Wiklund I. Validation of a 4-graded scale for severity of heartburn in symptomatic GERD patients [abstract]. Gut 2004; 53 (Suppl. VI): A103.
-
(2004)
Gut
, vol.53
, Issue.SUPPL. VI
-
-
Junghard, O.1
Wiklund, I.2
-
21
-
-
0028508838
-
Nonsteroidal antiinflammatory drugs and the gastrointestinal tract
-
Hirschowitz BI. Nonsteroidal antiinflammatory drugs and the gastrointestinal tract. Gastroenterologist 1994; 2: 207-23.
-
(1994)
Gastroenterologist
, vol.2
, pp. 207-223
-
-
Hirschowitz, B.I.1
-
22
-
-
0032923370
-
The epidemiology of non-steroidal anti-inflammatory drugs
-
Tenenbaum J. The epidemiology of non-steroidal anti-inflammatory drugs. Can J Gastroenterol 1999; 13: 119-22.
-
(1999)
Can J Gastroenterol
, vol.13
, pp. 119-122
-
-
Tenenbaum, J.1
-
23
-
-
1542377480
-
Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease
-
Johnson DA, Fennerty MB. Heartburn severity underestimates erosive esophagitis severity in elderly patients with gastroesophageal reflux disease. Gastroenterology 2004; 126: 660-4.
-
(2004)
Gastroenterology
, vol.126
, pp. 660-664
-
-
Johnson, D.A.1
Fennerty, M.B.2
-
25
-
-
0033636764
-
Nonsteroidal anti-inflammatory drug gastropathy at the new millennium: Mechanisms and prevention
-
Rich M, Scheiman JM. Nonsteroidal anti-inflammatory drug gastropathy at the new millennium: mechanisms and prevention. Semin Arthritis Rheum 2000; 30: 167-79.
-
(2000)
Semin Arthritis Rheum
, vol.30
, pp. 167-179
-
-
Rich, M.1
Scheiman, J.M.2
-
26
-
-
0021256898
-
Effect of indomethacin on basal and histamine-stimulated human gastric acid secretion
-
Levine RA, Schwartzel EH. Effect of indomethacin on basal and histamine-stimulated human gastric acid secretion. Gut 1984; 25: 718-22.
-
(1984)
Gut
, vol.25
, pp. 718-722
-
-
Levine, R.A.1
Schwartzel, E.H.2
-
27
-
-
0031959523
-
Effect of one-month treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) on gastric pH of rheumatoid arthritis patients
-
Savarino V, Mela GS, Zentilin P, et al. Effect of one-month treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) on gastric pH of rheumatoid arthritis patients. Dig Dis Sci 1998; 43: 459-63.
-
(1998)
Dig Dis Sci
, vol.43
, pp. 459-463
-
-
Savarino, V.1
Mela, G.S.2
Zentilin, P.3
-
28
-
-
0033082191
-
Gastric emptying of solids in long-term NSAID users: Correlation with endoscopic findings and Helicobacter pylori status
-
Kulkarni SG, Parikh SS, Shankhpal PD, et al. Gastric emptying of solids in long-term NSAID users: correlation with endoscopic findings and Helicobacter pylori status. Am J Gastroenterol 1999; 94: 382-6.
-
(1999)
Am J Gastroenterol
, vol.94
, pp. 382-386
-
-
Kulkarni, S.G.1
Parikh, S.S.2
Shankhpal, P.D.3
-
29
-
-
11144335481
-
Effect of cyclooxygenase inhibitors on gastric emptying and small intestinal transit in humans
-
Bouras EP, Burton DD, Camilleri M, Stephens DA, Thomforde GM. Effect of cyclooxygenase inhibitors on gastric emptying and small intestinal transit in humans. Neurogastroenterol Motil 2004; 16: 729-35.
-
(2004)
Neurogastroenterol Motil
, vol.16
, pp. 729-735
-
-
Bouras, E.P.1
Burton, D.D.2
Camilleri, M.3
Stephens, D.A.4
Thomforde, G.M.5
|